AshleyFlynn(Flynn)WardMD
Pediatric Hematology & Oncology • Rockville, MDVice President, Clinical Development
Dr. Ward is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9704 Medical Center Drive
Rockville, MD 20850Phone+1 240-620-8389
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2007 - 2010
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 2003 - 2007- Washington University in St. Louis School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2007 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 20 citationsFDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell CarcinomaDiana Bradford, Suzanne Demko, Susan Jin, Pallavi S. Mishra-Kalyani, Aaliyah R. Beckles
The Oncologist. 2020-07-01 - 2 citationsCorrection: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/on...John C. Byrd, Stephen C. Smith, Nina D. Wagner-Johnston, Jeff P. Sharman, Andy I. Chen
Oncotarget. 2019-01-01 - 29 citationsFirst-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL.John C Byrd, Stephen Smith, Nina Wagner-Johnston, Jeff Sharman, Andy I Chen
Oncotarget. 2018-02-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
